Laboratorios Farmaceuticos ROVI produces and sells pharmaceutical products. The Company's principal product is Bemiparin, a low molecular weight heparin. Its prescription products comprise Hibor to prevent thromboembolic disease; Hirobriz, Breezhale, and Ulunar Breezhaler for chronic obstructive pulmonary disease; Volutsa for the treatment of moderate to severe storage systems symptoms; and Medikinet and Medicebran for attention deficit and hyperactivity disorder. The Company's prescription products also include Exxiv for the symptoms of rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis; Neparvis for treatment of symptomatic chronic heart failure with reduced ejection.